Topaz et al (J Am Col Cardiol 2023;81:119, PMID 36631206) developed a technique for
treating pocket infections in patients with cardiac implantable electronic devices
(CIEDs) such as pacemakers and implantable cardioverter-defibrillators who were deemed
too high risk for lead and device extraction because of age, comorbidities, or frailty.
The developed technique is a way to deliver continuous, in situ-targeted, ultrahigh
concentration of antibiotics (CITA) directly into the pocket. The article describes
the results in all patients treated with CITA between 2007 and March 2021 as a cohort
study. Given promising early results, the investigators later expanded the indication
to patients looking to avoid lead extraction. Patients approached for treatment with
CITA had to have local infection without signs of systemic infection, such as fever,
positive blood cultures, or vegetation on leads. The cohort of 80 patients treated
with CITA were further divided into 3 groups: extraction prohibited owing to perceived
high risk (n = 9), debatable indication for lead extraction such as possible infection
(n = 6), and patients with pocket infection who could undergo extraction but who preferred
CITA (n = 65). This final group was compared with 81 patients who underwent lead/device
extraction for pocket infection in a case-control study.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Heart RhythmAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Published online: February 01, 2023
Footnotes
Funding Sources: The author has no funding sources to disclose.
Disclosures: The author has no conflicts of interest to disclose.
Identification
Copyright
No Copyright Notice
